Effect of dipeptidyl peptidase-4 inhibitors on heart failure: A meta-analysis of randomized clinical trials
© 2016 Elsevier Ireland Ltd. All rights reserved. Background: Recent studies have suggested that dipeptidyl peptidase-4 inhibitors (DPP-4 inhibitors) may be associated with increased risk of heart failure (HF), but evidence was inconclusive. We aimed to determine the effects of DPP-4 inhibitors on r...
Saved in:
Main Authors: | Kongwatcharapong J., Dilokthornsakul P., Nathisuwan S., Phrommintikul A., Chaiyakunapruk N. |
---|---|
Format: | Journal |
Published: |
2017
|
Online Access: | https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=84962810190&origin=inward http://cmuir.cmu.ac.th/jspui/handle/6653943832/41884 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | Chiang Mai University |
Similar Items
-
Effect of dipeptidyl peptidase-4 inhibitors on heart failure: A meta-analysis of randomized clinical trials
by: J. Kongwatcharapong, et al.
Published: (2018) -
Dipeptidyl peptidase-4 inhibitors and the ischemic heart: Additional benefits beyond glycemic control
by: Nipon Chattipakorn, et al.
Published: (2018) -
Dipeptidyl peptidase-4 inhibitors and the ischemic heart: Additional benefits beyond glycemic control
by: Chattipakorn N., et al.
Published: (2017) -
Navigating the chemical space of dipeptidyl peptidase-4 inhibitors
by: Watshara Shoombuatong, et al.
Published: (2015) -
Cost-effectiveness of dipeptidyl peptidase-4 inhibitor monotherapy versus sulfonylurea monotherapy for people with type 2 diabetes and chronic kidney disease in Thailand
by: Permsuwan U., et al.
Published: (2017)